KYGEVVI

DOXECITINE AND DOXRIBTIMINE · UCB, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KYGEVVI, covering 2025-11-03 to 2026-04-15. Get the full timeline:

Most recent: EMA Authorised: Kygevvi (doxecitine;Doxribtimine) — UCB Pharma